中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
10期
12-13
,共2页
血管神经性头痛%临床疗效%安全性
血管神經性頭痛%臨床療效%安全性
혈관신경성두통%림상료효%안전성
Angioneurotic headache%Clinical efficacy%Security
目的:探讨中西医结合治疗血管神经性头痛的临床应用价值及安全性.方法:将本院收治的86例血管神经性头痛患者随机分为观察组和对照组,对照组给予常规西药治疗,观察组在对照组治疗的基础上给予自拟的止痛活血汤治疗,观察两组的临床疗效和不良反应发生率.结果:观察组临床总有效率为90.7%,对照组临床总有效率为62.8%,两组临床疗效差异有统计学意义(P<0.05);观察组不良反应发生率为23.3%,对照组不良反应发生率为25.6%,两组安全性差异无统计学意义(P>0.05).结论:中西医结合疗法能显著提高血管神经性头痛的临床疗效,不良反应发生率未见增高,具有重要的临床应用价值.
目的:探討中西醫結閤治療血管神經性頭痛的臨床應用價值及安全性.方法:將本院收治的86例血管神經性頭痛患者隨機分為觀察組和對照組,對照組給予常規西藥治療,觀察組在對照組治療的基礎上給予自擬的止痛活血湯治療,觀察兩組的臨床療效和不良反應髮生率.結果:觀察組臨床總有效率為90.7%,對照組臨床總有效率為62.8%,兩組臨床療效差異有統計學意義(P<0.05);觀察組不良反應髮生率為23.3%,對照組不良反應髮生率為25.6%,兩組安全性差異無統計學意義(P>0.05).結論:中西醫結閤療法能顯著提高血管神經性頭痛的臨床療效,不良反應髮生率未見增高,具有重要的臨床應用價值.
목적:탐토중서의결합치료혈관신경성두통적림상응용개치급안전성.방법:장본원수치적86례혈관신경성두통환자수궤분위관찰조화대조조,대조조급여상규서약치료,관찰조재대조조치료적기출상급여자의적지통활혈탕치료,관찰량조적림상료효화불량반응발생솔.결과:관찰조림상총유효솔위90.7%,대조조림상총유효솔위62.8%,량조림상료효차이유통계학의의(P<0.05);관찰조불량반응발생솔위23.3%,대조조불량반응발생솔위25.6%,량조안전성차이무통계학의의(P>0.05).결론:중서의결합요법능현저제고혈관신경성두통적림상료효,불량반응발생솔미견증고,구유중요적림상응용개치.
Objective:To explore the clinical value and safety of integrative therapy for angioneurotic headache.Method:86 cases of patients with angioneurotic headache were randomly divided into the observation group and the control group in our hospital,the control group was given conventional western medicine,the observation group were given the decoction of chinese medicine on the basis of the control group,to observe the clinical efficacy and incidence of adverse reactions. Result:The total effective rate of the observation group was 90.7%,the total effective rate of the control group was 62.8%, there were significant differences in the two groups(P<0.05);the incidence of adverse reactions of the observation group was 23.3%,the incidence of adverse reactions of the control group was 25.6%,there were no significant differences in the two groups(P>0.05).Conclusion:Integrative therapy can significantly improve the clinical efficacy of angioneurotic headache,no change in the incidence of adverse reactions,it has important clinical value.